参考文献/References:
[1] Targher G,Day CP,Bonora E.Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease[J].N Engl J Med,2010(363):1341-1350.
[2] Younossi Z,Anstee QM,Marietti M,et al.Global burden of NAFLD and NASH:Trends,predictions,risk factors and prevention[J].Nat Rev Gastroenterol Hepatol,2018,15(1):11-20.
[3] Farrell GC,Larter CZ.Nonalcoholic fatty liver disease:From steatosis to cirrhosis[J].Hepatology,2006,43(1):99-112.
[4] Imanishi Y,Maeda N,Otogawa K,et al.Herb medicine Inchin-ko-to(TJ-135)regulates PDGF-BB-dependent signaling pathways of hepatic stellate cells in primary culture and attenuates development of liver fibrosis induced by thioacetamide administration in rats[J].J Hepatol,2004,41(2):242-250.
[5] Chor SY,Hui AY.Anti-proliferative and pro-apoptotic effects of herbal medicine on hepatic stellate cell[J].J Ethnopharmacol,2005,100(2):180-186.
[6] 邱 勇.桃红四物汤对CCl4诱导肝纤维化小鼠治疗作用及其机制研究[J].陕西中医,2019,40(12):1673-1675.
[7] 韩艳珍,单铁英,李 伟,等.口服枸杞多糖对小鼠肝纤维化组织基质金属蛋白酶-2及基质金属蛋白酶-2抑制剂水平影响的实验研究[J].陕西医学杂志,2021,50(3):276-279.
[8] 戈升荣,俞一心,谢更新.丹酚酸的药理作用研究进展[J].中药材,2002,25(9):683-686.
[9] 雷 玲,闵 珺,刘 锋,等.黄芪对肝纤维化大鼠肝损伤保护作用及机制研究[J].陕西中医,2020,41(9):1192-1196.
[10] 马 进,郑仕中,陆 茵,等.川芎嗪抑制肝纤维化作用机制的研究进展[J].中国临床药理学杂志,2010,26(5):395-398.
[11] Li JY,Cao HY,Sun L,et al.Therapeutic mechanism of Yīn-Chen-Hāo decoction in hepatic diseases[J].World J Gastroenterol,2017,23(7):1125-1138.
[12] 李京涛,焦俊喆,魏海梁,等.茵陈蒿汤对急性肝内胆汁淤积大鼠肠道黏膜屏障和NF-κB的影响[J].陕西中医,2019,40(5):547-549.
[13] Hui Y,Wang X,Yu Z,et al.Scoparone as a therapeutic drug in liver diseases:Pharmacology,pharmacokinetics and molecular mechanisms of action[J].Pharmacol Res,2020(160):105170.
[14] Kleiner DE,Brunt EM,Van Natta M,et al.Design and validation of a histological scoring system for nonalcoholic fatty liver disease[J].Hepatology,2005,41(6):1313-1321.
[15] 何 聪,孔 婧,王慧超,等.祛湿化瘀法治疗非酒精性脂肪肝研究进展[J].陕西中医,2020,41(2):165-167.
[16] 胡菲菲,郝占霞,张少波,等.生制何首乌水提物改善MCD饲料诱导小鼠非酒精性脂肪性肝炎的研究[J].中国中医药杂志,2020,45(19):4732-4739.
[17] 王 莎,王林元,瞿 研,等.阿萨伊对非酒精性脂肪性肝炎大鼠的保护作用及其健脾化浊功效研究[J].中国中医药杂志,2018,33(4):1348-1352.
[18] Imanishi Y,Maeda N,Otogawa K,et al.Herb medicine Inchin-ko-to(TJ-135)regulates PDGF-BB-dependent signaling pathways of hepatic stellate cells in primary culture and attenuates development of liver fibrosis induced by thioacetamide administration in rats[J].Journal of Hepatology,2004,41(2):242-250.
[19] Atmaca M,Bilgin HM,Obay BD,et al.The hepatoprotective effect of coumarin and coumarin derivates on carbon tetrachloride-induced hepatic injury by antioxidative activities in rats[J].J Physiol Biochem,2011,67(4):569-576.
[20] 陈小青,任俞霏,孔维宗,等.丹酚酸B对非酒精性脂肪性肝病细胞模型氧化应激的影响[J].临床肝胆病杂志,2018,34(10):2175-2181.
[21] Lee K,Nelson CM.New insights into the regulation of epithelial—mesenchymal transition and tissue fibrosis[J].International Review of Cell And Molecular Biology,2012,294(2):171-221.
[22] Zong L,Qu Y,Xu MY,et al.18α-glycyrrhetinic acid down-regulates expression of type Ⅰ and Ⅲ collagen via TGF-β1/Smad signaling pathway in human and rat hepatic stellate cells[J].Int J Med Sci,2012,9(5):370-379.
[23] Gao X,Cao Y,Yang W,et al.BMP2 inhibits TGF-β-induced pancreatic stellate cell activation and extracellular matrix formation[J].Am J Physiol Gastrointest Liver Physiol,2013,304(9):804-813.